GleamWall
中文EN

HCA HCA Healthcare, Inc.

Services-General Medical & Surgical Hospitals, NEC · NYSE · SEC CIK 860730 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY5.8%
TTM net income YoY6.8%
TTM EPS YoY16.6%
Revenue 3-yr CAGR7.6%
Net income 3-yr CAGR5.8%

Margins

Gross margin—
Operating margin—
Net margin8.6%
FCF margin7.6%
EBITDA margin—

Returns

ROE—
ROA11.0%
ROIC (approx.)—
Asset turnover1.28x

Leverage & solvency

Liabilities / assets107.2%
Debt / equity—
Current ratio0.82x
Interest coverage—

Cash quality & payout

Operating cash flow / net income1.65x
Accruals ratio-7.1%
Payout ratio10.1%
Capex / revenue6.6%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$19.85B$20.23B$19.11B$19.51B$19.16B$18.61B$18.32B$18.29B
SG&A expense$146.00M$148.00M$133.00M$153.00M$139.00M$130.00M$126.00M$120.00M
Interest expense$607.00M$599.00M$584.00M$572.00M$561.00M$568.00M$547.00M$528.00M
Pretax income$2.37B$2.49B$2.29B$2.67B$2.42B$2.42B$2.33B$2.13B
Income tax$521.00M$564.00M$430.00M$509.00M$515.00M$524.00M$502.00M$447.00M
Net income$1.58B$1.70B$1.62B$1.88B$1.64B$1.65B$1.61B$1.44B
EPS (basic)7.367.707.25—7.056.916.52—
EPS (diluted)7.277.627.15—6.966.836.45—
Dividends declared per share0.780.780.780.720.720.720.720.66
Weighted avg. shares (diluted)217.21M222.83M226.65M—236.18M241.91M249.44M—
Balance sheet
Cash & equivalents$908.00M$1.01B$940.00M$1.04B$997.00M$939.00M$1.06B$1.93B
Receivables$11.51B$12.28B$11.32B$10.87B$10.43B$10.46B$11.09B$10.75B
Inventory$1.67B$1.66B$1.68B$1.65B$1.73B$1.79B$1.79B$1.74B
Current assets$16.22B$17.19B$16.05B$15.78B$15.29B$15.56B$16.26B$16.41B
PP&E, net$32.27B$31.82B$31.47B$31.14B$30.57B$30.12B$29.74B$29.41B
Total assets$63.45B$63.25B$61.45B$60.72B$59.75B$59.54B$59.80B$59.51B
Current liabilities$19.78B$17.31B$19.26B$16.35B$17.90B$15.94B$13.63B$15.18B
Short-term debt$8.09B$6.26B$8.53B$4.89B$6.11B$5.10B$3.52B$4.70B
Long-term debt$42.40B$43.45B$39.49B$41.60B$38.40B$39.38B$41.06B$38.33B
Total debt$50.49B$49.72B$48.02B$46.49B$44.51B$44.48B$44.58B$43.03B
Total liabilities$68.05B$66.46B$64.43B$63.49B$61.91B$60.77B$60.24B$58.96B
Shareholders' equity-$8.08B-$6.64B-$6.30B-$6.03B-$5.33B-$4.39B-$3.52B-$2.50B
Net debt$49.59B$48.70B$47.08B$45.45B$43.51B$43.54B$43.52B$41.10B
Shares outstanding210.88M217.96M222.53M224.61M229.85M236.14M242.96M249.98M
Cash flow statement
Operating cash flow$4.46B$2.33B$2.01B$2.36B$4.42B$4.21B$1.65B$2.56B
Capital expenditure$1.36B$1.23B$1.12B$1.49B$1.29B$1.18B$991.00M$1.28B
Free cash flow$3.10B$1.10B$895.00M$870.00M$3.13B$3.03B$660.00M$1.27B
Investing cash flow-$1.92B-$1.56B-$1.28B-$1.32B-$1.39B-$1.25B-$1.03B-$1.35B
Financing cash flow-$2.65B-$704.00M-$830.00M-$999.00M-$2.97B-$3.09B-$1.50B-$2.16B
Depreciation & amortization$954.00M$944.00M$930.00M$911.00M$889.00M$863.00M$860.00M$856.00M
Stock-based compensation$133.00M$85.00M$86.00M$100.00M$104.00M$99.00M$98.00M$85.00M
Dividends paid$165.00M$171.00M$183.00M$162.00M$166.00M$171.00M$180.00M$165.00M
Share buybacks$2.97B$2.06B$1.57B$2.56B$2.50B$2.50B$2.51B$1.70B

Free plan shows the latest 8 periods; Pro shows all 67 🔒

· This company does not report gross profit in XBRL.

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.